ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

Management of AF patients with ACS

Lankenau

P. Kowey, D. Ice

LAA Closure for Atrial Fibrillation using Occlusion Device

Congenital and Structural Interventions

H. Sievert

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …

Insights from 2024 ACP Annual Meeting

D. Berg

Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…

Cedars Sinai

W. Boden

Interview with Dr. Christopher Ellis: Left Atrial Appendage Manageme…

Georgia Heart Institute

D. Weisman, C. Ellis

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…

Complex Coronary Cases

U. Baber

Stroke Prevention in Atrial Fibrillation

Penn Medicine Heart and Vascular Center

D. Goldberg

ACC 2023: Can LAAC Be Considered a True Alternative to OAC?

ACC 2023 Conference Coverage

A. Natale

Peri-Operative Management of Anticoagulation

Icahn School of Medicine at Mount Sinai

A. Dunn

Aspirin for Primary Prevention

Salim Virani

Anticoagulation in ECLS - To Bleed, or Not to Clot...

UCLA Health

A. Young

Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?

Canadian Collaborative Research Network

M. Sabatine

AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Com…

AHA 2022 Conference Coverage

F. Bakaeen

Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…

Cardiometabolic Health Congress (CMHC)

D. Bhatt

AHA 2022: Bivalirudin With a Post-PCI High-Dose Infusion versus Hepa…

AHA 2022 Conference Coverage

G. W. Stone

A Revolutionary Approach to Left Atrial Appendage Closure - LAMINAR …

University of Miami

S. Kar